Document
IPR2015-01096, No. 2004 Exhibit - Pomalyst April 2015 Package Insert (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2004 Exhibit - Pomalyst April 2015 Package Insert (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 1006 Exhibit - Thalomid PI (P.T.A.B. Apr. 23, 2015)
Cite Document
IPR2015-01096, No. 1006 Exhibit - Thalomid PI (P.T.A.B. Apr. 23, 2015)
+ More Snippets
Document
IPR2015-01096, No. 1064 Exhibit - Diether et al RFS 2009 (P.T.A.B. Aug. 13, 2015)
Cite Document
IPR2015-01096, No. 1064 Exhibit - Diether et al RFS 2009 (P.T.A.B. Aug. 13, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2037 Exhibit - January 2014 SpangenbergIPNav threatened 720 patent obviousness IPR declaration (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2037 Exhibit - January 2014 SpangenbergIPNav threatened 720 patent obviousness IPR declaration (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2049 Exhibit - Law360 Shire Drugs Are Next Targets of Hedge Fund AIA Reviews 2015 (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2049 Exhibit - Law360 Shire Drugs Are Next Targets of Hedge Fund AIA Reviews 2015 (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2006 Exhibit - Uhl, Kathleen, et al Thalidomide Use in the US, Experience with Pregnancy Testing in the STEPS Programme 2006 (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2006 Exhibit - Uhl, Kathleen, et al Thalidomide Use in the US, Experience with Pregnancy Testing in the STEPS Programme 2006 (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2011 Exhibit - December 2005 Revlimid FDA approval letter (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2011 Exhibit - December 2005 Revlimid FDA approval letter (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 1054 Exhibit - Karpoff and Lou 2010 JF (P.T.A.B. Aug. 13, 2015)
Cite Document
IPR2015-01096, No. 1054 Exhibit - Karpoff and Lou 2010 JF (P.T.A.B. Aug. 13, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2003 Exhibit - Revlimid February 2015 Package Insert (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2003 Exhibit - Revlimid February 2015 Package Insert (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2051 Exhibit - Reuters US hedge fund plans to take on big pharma over patents 2015 (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2051 Exhibit - Reuters US hedge fund plans to take on big pharma over patents 2015 (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2066 Exhibit - STEPS Instructions for Physicians (P.T.A.B. Feb. 12, 2016)
Cite Document
IPR2015-01096, No. 2066 Exhibit - STEPS Instructions for Physicians (P.T.A.B. Feb. 12, 2016)
+ More Snippets
Document
IPR2015-01096, No. 1048 Exhibit - AIA House subcomittee hearing (P.T.A.B. Aug. 13, 2015)
Cite Document
IPR2015-01096, No. 1048 Exhibit - AIA House subcomittee hearing (P.T.A.B. Aug. 13, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2039 Exhibit - January 2014 SpangenbergIPNav threatened 720 patent anticipation IPR declaration (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2039 Exhibit - January 2014 SpangenbergIPNav threatened 720 patent anticipation IPR declaration (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2033 Exhibit - January 2014 SpangenbergIPNav email threatening IPRs (P.T.A.B. Jul. 30, 2015)
Cite Document
IPR2015-01096, No. 2033 Exhibit - January 2014 SpangenbergIPNav email threatening IPRs (P.T.A.B. Jul. 30, 2015)
+ More Snippets
Document
IPR2015-01096, No. 2022 Exhibit - Center for Drug Evaluation and Research, FDA Transcript 47th Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee 1997 (P.T.A.B. Jul. 3...
Cite Document
IPR2015-01096, No. 2022 Exhibit - Center for Drug Evaluation and Research, FDA Transcript 47th Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee 1997 (P.T.A.B. Jul. 30, 2015)
+ More Snippets